1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Skin Ulcers Global Clinical Trials Review, H2, 2015

Skin Ulcers Global Clinical Trials Review, H2, 2015

  • August 2015
  • -
  • Global Data
  • -
  • 73 pages

Skin Ulcers Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Skin Ulcers Global Clinical Trials Review, H2, 2015" provides an overview of Skin Ulcers clinical trials scenario. This report provides top line data relating to the clinical trials on Skin Ulcers. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Skin Ulcers Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Skin Ulcers 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Skin Ulcers to Dermatology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Skin Ulcers to Dermatology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Skin Ulcers 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Skin Ulcers Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
XOMA Corporation 33
Clinical Trial Overview of XOMA Corporation 33
Healthpoint Biotherapeutics (Inactive) 34
Clinical Trial Overview of Healthpoint Biotherapeutics (Inactive) 34
Nitta Gelatin India Limited 35
Clinical Trial Overview of Nitta Gelatin India Limited 35
NB Therapeutics, Inc. 36
Clinical Trial Overview of NB Therapeutics, Inc. 36
Abbott Laboratories 37
Clinical Trial Overview of Abbott Laboratories 37
Aurous HealthCare Research and Development India Private Limited 38
Clinical Trial Overview of Aurous HealthCare Research and Development India Private Limited 38
AnGes MG, Inc. 39
Clinical Trial Overview of AnGes MG, Inc. 39
Andaluz Health Service 40
Clinical Trial Overview of Andaluz Health Service 40
Air Liquide S.A. 41
Clinical Trial Overview of Air Liquide S.A. 41
ACR Biologics, LLC 42
Clinical Trial Overview of ACR Biologics, LLC 42
Clinical Trial Overview of Top Institutes / Government 43
Tehran University of Medical Sciences 43
Clinical Trial Overview of Tehran University of Medical Sciences 43
Hospital Universitario Central de Asturias 44
Clinical Trial Overview of Hospital Universitario Central de Asturias 44
U.S. Department of Veterans Affairs 45
Clinical Trial Overview of U.S. Department of Veterans Affairs 45
Basque Health Service 46
Clinical Trial Overview of Basque Health Service 46
Bayside Health 47
Clinical Trial Overview of Bayside Health 47
De La Salle University Medical Center 48
Clinical Trial Overview of De La Salle University Medical Center 48
Department of Health, South Africa 49
Clinical Trial Overview of Department of Health, South Africa 49
Ghent University 50
Clinical Trial Overview of Ghent University 50
Higashi Washinomiya Hospital 51
Clinical Trial Overview of Higashi Washinomiya Hospital 51
Five Key Clinical Profiles 52
Appendix 70
Abbreviations 70
Definitions 70
Research Methodology 71
Secondary Research 71
About GlobalData 72
Contact Us 72
Disclaimer 72
Source 73

List of Tables
Skin Ulcers Therapeutics, Global, Clinical Trials by Region, 2015* 7
Skin Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Skin Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Skin Ulcers Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Skin Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Skin Ulcers Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Skin Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Skin Ulcers Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Skin Ulcers to Dermatology Clinical Trials, G7 Countries (%), 2015* 15
Skin Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Skin Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Skin Ulcers to Dermatology Clinical Trials, E7 Countries (%), 2015* 18
Skin Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Skin Ulcers Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Skin Ulcers Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Skin Ulcers Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Skin Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Skin Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Skin Ulcers Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Skin Ulcers Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Skin Ulcers Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Skin Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Skin Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Skin Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Skin Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Skin Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by XOMA Corporation, 2015* 33
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Healthpoint Biotherapeutics (Inactive), 2015* 34
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Nitta Gelatin India Limited, 2015* 35
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by NB Therapeutics, Inc., 2015* 36
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 37
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Aurous HealthCare Research and Development India Private Limited, 2015* 38
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2015* 39
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Andaluz Health Service, 2015* 40
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Air Liquide S.A., 2015* 41
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by ACR Biologics, LLC, 2015* 42
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 43
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitario Central de Asturias, 2015* 44
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2015* 45
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Basque Health Service, 2015* 46
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayside Health, 2015* 47
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by De La Salle University Medical Center, 2015* 48
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2015* 49
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Ghent University, 2015* 50
Skin Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Higashi Washinomiya Hospital, 2015* 51

List of Figures
Skin Ulcers Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Skin Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Skin Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Skin Ulcers Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Skin Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Skin Ulcers Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Skin Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Skin Ulcers Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Skin Ulcers to Dermatology Clinical Trials, G7 Countries (%), 2015* 15
Skin Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Skin Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Skin Ulcers to Dermatology Clinical Trials, E7 Countries (%), 2015* 18
Skin Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Skin Ulcers Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Skin Ulcers Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Skin Ulcers Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Skin Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Skin Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Skin Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Skin Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Skin Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Skin Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Skin Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 71

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.